Total Payments
$1,268
2024 Payments
$177.33
Companies
19
Transactions
83
Medicare Patients
241
Medicare Billing
$5,141
Payment Breakdown by Category
Food & Beverage$1,268 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,268 | 83 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $207.42 | 19 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $173.55 | 10 | $0 (2024) |
| PFIZER INC. | $170.98 | 14 | $0 (2023) |
| Merck Sharp & Dohme LLC | $126.28 | 7 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $119.71 | 8 | $0 (2023) |
| ABBVIE INC. | $86.45 | 4 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $71.02 | 3 | $0 (2023) |
| Novo Nordisk Inc | $48.46 | 3 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $46.48 | 2 | $0 (2023) |
| Amgen Inc. | $37.86 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $177.33 | 8 | ABBVIE INC. ($70.21) |
| 2023 | $957.66 | 66 | Lilly USA, LLC ($182.52) |
| 2022 | $133.16 | 9 | Novartis Pharmaceuticals Corporation ($31.98) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Inflammation | ||||||
| 05/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.70 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $31.50 | General |
| Category: Respiratory | ||||||
| 03/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.20 | General |
| 02/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Inflammation | ||||||
| 02/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2024 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 12/20/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Gastroenterology | ||||||
| 12/19/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Diabetes | ||||||
| 10/27/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Diabetes | ||||||
| 10/19/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Diabetes | ||||||
| 10/05/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/30/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Diabetes | ||||||
| 09/29/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/22/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: UROLOGY | ||||||
| 09/12/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: Diabetes | ||||||
| 09/11/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Diabetes | ||||||
| 09/07/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/05/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.28 | General |
| Category: PSYCHIATRY | ||||||
| 08/25/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $3.80 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/24/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ARALAST (Biological) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 71 | 87 | $3,783 | $1,720 |
| 2020 | 6 | 170 | 298 | $17,538 | $3,421 |
Total Patients
241
Total Services
385
Medicare Billing
$5,141
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 25 | 28 | $2,520 | $1,408 | 55.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 11 | 13 | $481.00 | $210.60 | 43.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 35 | 46 | $782.00 | $101.20 | 12.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 64 | 72 | $11,592 | $1,413 | 12.2% |
| 87804 | Detection test for influenza virus | Office | 2020 | 37 | 80 | $3,040 | $1,298 | 42.7% |
| 87880 | Strep test (streptococcus, group a) | Office | 2020 | 26 | 28 | $1,064 | $453.60 | 42.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 17 | 33 | $1,188 | $207.72 | 17.5% |
| 81002 | Urinalysis, manual test | Office | 2020 | 11 | 13 | $78.00 | $44.33 | 56.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2020 | 15 | 72 | $576.00 | $4.56 | 0.8% |
About Dalice Roberson
Dalice Roberson is a Physician Assistant healthcare provider based in Corbin, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/05/2018. The National Provider Identifier (NPI) number assigned to this provider is 1508336389.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dalice Roberson has received a total of $1,268 in payments from pharmaceutical and medical device companies, with $177.33 received in 2024. These payments were reported across 83 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,268).
As a Medicare-enrolled provider, Roberson has provided services to 241 Medicare beneficiaries, totaling 385 services with total Medicare billing of $5,141. Data is available for 2 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Corbin, KY
- Active Since 12/05/2018
- Last Updated 09/06/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1508336389
Products in Payments
- ELIQUIS (Drug) $170.98
- ENTRESTO (Drug) $119.71
- FARXIGA (Drug) $97.25
- MOUNJARO (Drug) $86.14
- REXULTI (Drug) $82.93
- TRULICITY (Drug) $76.35
- BREZTRI (Drug) $76.30
- GEMTESA (Drug) $71.02
- VRAYLAR (Drug) $68.89
- STEGLATRO (Drug) $56.34
- Rybelsus (Drug) $48.46
- BELSOMRA (Drug) $38.61
- Otezla (Drug) $37.86
- JARDIANCE (Drug) $35.80
- INGREZZA (Drug) $27.47
- Cologuard Collection Kit (Device) $21.00
- VERQUVO (Drug) $18.65
- Crysvita (Drug) $17.56
- UBRELVY (Drug) $17.56
- SHINGRIX (Biological) $15.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Corbin
Ingrid Minor, Pa-C, PA-C
Physician Assistant — Payments: $10,579
Physician Assistant $10,579
Kristen Wells, Pa-C, PA-C
Physician Assistant — Payments: $7,536
Physician Assistant $7,536
Sara Chasteen, Pa-C, PA-C
Physician Assistant — Payments: $6,490
Physician Assistant $6,490
Bridgette Hubbard, Pa-C, PA-C
Physician Assistant — Payments: $4,763
Physician Assistant $4,763
Devin Edwards, Pa-C, PA-C
Physician Assistant — Payments: $3,616
Physician Assistant $3,616
Jonathan Smith, Pa - C, PA - C
Physician Assistant — Payments: $3,417
Physician Assistant $3,417